CD26+ T cells infiltrate the skin and intestinal tract in clinical GVHD, and these results strongly suggest that CD26 assists T-cell migration across the endothelial barrier, as well as a role for CD26+ T cells in the pathophysiology of GVHD [52,53]. The gene discussed is DPP4; the disease is graft versus host disease.